Lund, Sweden, 16 December 2025. Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that GOOD-IDES-02, a global pivotal Phase 3 trial in anti-glomerular basement membrane (anti-GBM) ...
The carbon black market is poised for growth driven by its use in tire production, expanding automotive, and manufacturing ...
In this article, authors Srikanth Daggumalli and Arun Lakshmanan discuss next-generation context-aware conversational search ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results